Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures

Mehdi Javanbakht; Ali Keshtkaran; Hossien Shabaninejad; Hassan Karami; Maryam Zakerinia; Sajad Delavari

doi:10.15171/ijhpm.2015.113

Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures

Mehdi Javanbakht, Ali Keshtkaran, Hossien Shabaninejad, Hassan Karami, Maryam Zakerinia, Sajad Delavari

Health Economics Research Unit

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)

11 Downloads (Pure)

Abstract

BACKGROUND: β-Thalassemia is a prevalent genetic disease in Mediterranean countries. The most common treatments for this disease are blood transfusion plus iron chelation (BTIC) therapy and bone marrow transplantation (BMT). Patients using these procedures experience different health-related quality of life (HRQoL). The purpose of the present study was to measure HRQoL in these patients using 2 different multiattribute quality of life (QoL) scales.

METHODS: In this cross-sectional study, data were gathered using 3 instruments: a socio-demographic questionnaire, EQ-5D, and SF-36. A total of 196 patients with β-thalassemia were randomly selected from 2 hospitals in Shiraz (Southern Iran). Data were analyzed using logistic regression and multiple regression models to identify factors that affect the patients' HRQoL.

RESULTS: The average EQ-5D index and EQ visual analog scale (VAS) scores were 0.86 (95% CI: 0.83-0.89) and 71.85 (95% CI: 69.13-74.58), respectively. Patients with BMT reported significantly higher EQ VAS scores (83.27 vs 68.55, respectively). The results showed that patients who lived in rural area and patients with BMT reported higher EQ VAS scores (rural; β= 10.25, P = .006 and BMT; β= 11.88, P = .000). As well, SF-36 between 2 groups of patients were statistically significant in physical component scale (PCS).

CONCLUSION: Patients in the BMT group experienced higher HRQoL in both physical and mental aspects compared to those in the BTIC group. More studies are needed to assess the relative cost-effectiveness of these methods in developing countries.

Original language	English
Pages (from-to)	733-740
Number of pages	8
Journal	International journal of health policy and management
Volume	4
Issue number	11
Early online date	13 Jun 2015
DOIs	https://doi.org/10.15171/ijhpm.2015.113
Publication status	Published - Nov 2015

Bibliographical note

Date of Acceptance: 08/06/2015
© 2015 by Kerman University of Medical Sciences.

Acknowledgments
The present article was extracted from the thesis written by Hassan Karami and was financially supported by Shiraz University of Medical Sciences, Shiraz, Iran (grant No. 6292). The authors would like to thank all participants in the study

IJHPM supports the Open Access initiative. Abstracts and full texts (PDF format) of all articles published by IJHPM are freely accessible to everyone immediately upon publication. IJHPM also does not charge any submission or publication fees.

Keywords

β-Thalassemia
Health Related Quality of Life (HRQoL)
blood transfusion
bone marrow transplantation

Access to Document

10.15171/ijhpm.2015.113Licence: Unspecified

Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/
Final published version, 648 KB

Cite this

Javanbakht, M., Keshtkaran, A., Shabaninejad, H., Karami, H., Zakerinia, M., & Delavari, S. (2015). Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures. International journal of health policy and management, 4(11), 733-740. https://doi.org/10.15171/ijhpm.2015.113

Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures. / Javanbakht, Mehdi; Keshtkaran, Ali; Shabaninejad, Hossien et al.
In: International journal of health policy and management, Vol. 4, No. 11, 11.2015, p. 733-740.

Research output: Contribution to journal › Article › peer-review

Javanbakht, M, Keshtkaran, A, Shabaninejad, H, Karami, H, Zakerinia, M & Delavari, S 2015, 'Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures', International journal of health policy and management, vol. 4, no. 11, pp. 733-740. https://doi.org/10.15171/ijhpm.2015.113

Javanbakht M, Keshtkaran A, Shabaninejad H, Karami H, Zakerinia M, Delavari S. Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures. International journal of health policy and management. 2015 Nov;4(11):733-740. Epub 2015 Jun 13. doi: 10.15171/ijhpm.2015.113

@article{85d4e3bffedb49cdbe696bf0aa1d2e6a,

title = "Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures",

abstract = "BACKGROUND: β-Thalassemia is a prevalent genetic disease in Mediterranean countries. The most common treatments for this disease are blood transfusion plus iron chelation (BTIC) therapy and bone marrow transplantation (BMT). Patients using these procedures experience different health-related quality of life (HRQoL). The purpose of the present study was to measure HRQoL in these patients using 2 different multiattribute quality of life (QoL) scales.METHODS: In this cross-sectional study, data were gathered using 3 instruments: a socio-demographic questionnaire, EQ-5D, and SF-36. A total of 196 patients with β-thalassemia were randomly selected from 2 hospitals in Shiraz (Southern Iran). Data were analyzed using logistic regression and multiple regression models to identify factors that affect the patients' HRQoL.RESULTS: The average EQ-5D index and EQ visual analog scale (VAS) scores were 0.86 (95% CI: 0.83-0.89) and 71.85 (95% CI: 69.13-74.58), respectively. Patients with BMT reported significantly higher EQ VAS scores (83.27 vs 68.55, respectively). The results showed that patients who lived in rural area and patients with BMT reported higher EQ VAS scores (rural; β= 10.25, P = .006 and BMT; β= 11.88, P = .000). As well, SF-36 between 2 groups of patients were statistically significant in physical component scale (PCS).CONCLUSION: Patients in the BMT group experienced higher HRQoL in both physical and mental aspects compared to those in the BTIC group. More studies are needed to assess the relative cost-effectiveness of these methods in developing countries.",

keywords = "β-Thalassemia, Health Related Quality of Life (HRQoL), blood transfusion, bone marrow transplantation",

author = "Mehdi Javanbakht and Ali Keshtkaran and Hossien Shabaninejad and Hassan Karami and Maryam Zakerinia and Sajad Delavari",

note = "Date of Acceptance: 08/06/2015 {\textcopyright} 2015 by Kerman University of Medical Sciences. Acknowledgments The present article was extracted from the thesis written by Hassan Karami and was financially supported by Shiraz University of Medical Sciences, Shiraz, Iran (grant No. 6292). The authors would like to thank all participants in the study IJHPM supports the Open Access initiative. Abstracts and full texts (PDF format) of all articles published by IJHPM are freely accessible to everyone immediately upon publication. IJHPM also does not charge any submission or publication fees.",

year = "2015",

month = nov,

doi = "10.15171/ijhpm.2015.113",

language = "English",

volume = "4",

pages = "733--740",

journal = "International journal of health policy and management",

issn = "2322-5939",

publisher = "Kerman University of Medical Science",

number = "11",

}

TY - JOUR

T1 - Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia

T2 - Application of SF-36, EQ-5D, and Visual Analogue Scale Measures

AU - Javanbakht, Mehdi

AU - Keshtkaran, Ali

AU - Shabaninejad, Hossien

AU - Karami, Hassan

AU - Zakerinia, Maryam

AU - Delavari, Sajad

N1 - Date of Acceptance: 08/06/2015 © 2015 by Kerman University of Medical Sciences. Acknowledgments The present article was extracted from the thesis written by Hassan Karami and was financially supported by Shiraz University of Medical Sciences, Shiraz, Iran (grant No. 6292). The authors would like to thank all participants in the study IJHPM supports the Open Access initiative. Abstracts and full texts (PDF format) of all articles published by IJHPM are freely accessible to everyone immediately upon publication. IJHPM also does not charge any submission or publication fees.

PY - 2015/11

Y1 - 2015/11

N2 - BACKGROUND: β-Thalassemia is a prevalent genetic disease in Mediterranean countries. The most common treatments for this disease are blood transfusion plus iron chelation (BTIC) therapy and bone marrow transplantation (BMT). Patients using these procedures experience different health-related quality of life (HRQoL). The purpose of the present study was to measure HRQoL in these patients using 2 different multiattribute quality of life (QoL) scales.METHODS: In this cross-sectional study, data were gathered using 3 instruments: a socio-demographic questionnaire, EQ-5D, and SF-36. A total of 196 patients with β-thalassemia were randomly selected from 2 hospitals in Shiraz (Southern Iran). Data were analyzed using logistic regression and multiple regression models to identify factors that affect the patients' HRQoL.RESULTS: The average EQ-5D index and EQ visual analog scale (VAS) scores were 0.86 (95% CI: 0.83-0.89) and 71.85 (95% CI: 69.13-74.58), respectively. Patients with BMT reported significantly higher EQ VAS scores (83.27 vs 68.55, respectively). The results showed that patients who lived in rural area and patients with BMT reported higher EQ VAS scores (rural; β= 10.25, P = .006 and BMT; β= 11.88, P = .000). As well, SF-36 between 2 groups of patients were statistically significant in physical component scale (PCS).CONCLUSION: Patients in the BMT group experienced higher HRQoL in both physical and mental aspects compared to those in the BTIC group. More studies are needed to assess the relative cost-effectiveness of these methods in developing countries.

AB - BACKGROUND: β-Thalassemia is a prevalent genetic disease in Mediterranean countries. The most common treatments for this disease are blood transfusion plus iron chelation (BTIC) therapy and bone marrow transplantation (BMT). Patients using these procedures experience different health-related quality of life (HRQoL). The purpose of the present study was to measure HRQoL in these patients using 2 different multiattribute quality of life (QoL) scales.METHODS: In this cross-sectional study, data were gathered using 3 instruments: a socio-demographic questionnaire, EQ-5D, and SF-36. A total of 196 patients with β-thalassemia were randomly selected from 2 hospitals in Shiraz (Southern Iran). Data were analyzed using logistic regression and multiple regression models to identify factors that affect the patients' HRQoL.RESULTS: The average EQ-5D index and EQ visual analog scale (VAS) scores were 0.86 (95% CI: 0.83-0.89) and 71.85 (95% CI: 69.13-74.58), respectively. Patients with BMT reported significantly higher EQ VAS scores (83.27 vs 68.55, respectively). The results showed that patients who lived in rural area and patients with BMT reported higher EQ VAS scores (rural; β= 10.25, P = .006 and BMT; β= 11.88, P = .000). As well, SF-36 between 2 groups of patients were statistically significant in physical component scale (PCS).CONCLUSION: Patients in the BMT group experienced higher HRQoL in both physical and mental aspects compared to those in the BTIC group. More studies are needed to assess the relative cost-effectiveness of these methods in developing countries.

KW - β-Thalassemia

KW - Health Related Quality of Life (HRQoL)

KW - blood transfusion

KW - bone marrow transplantation

U2 - 10.15171/ijhpm.2015.113

DO - 10.15171/ijhpm.2015.113

M3 - Article

C2 - 26673333

SN - 2322-5939

VL - 4

SP - 733

EP - 740

JO - International journal of health policy and management

JF - International journal of health policy and management

IS - 11

ER -

Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this